Home Markets US FDA puts Kezar Life Sciences’ lupus treatment trial on hold after patient deaths

US FDA puts Kezar Life Sciences’ lupus treatment trial on hold after patient deaths

Oct 05, 2024 comments off

Original source: https://www.investing.com/news/stock-market-news/us-fda-puts-clinical-hold-on-kezar-life-sciences-lupus-treatment-trial-3649995

You May Also Like

US stock futures inch lower with China trade talks, inflation data in focus

European Chemicals sector outlook for 2025 and 2026: UBS

UnitedHealth: Bernstein lists 3 top priorities for the new CEO

Israel stocks higher at close of trade; TA 35 up 0.03%

What’s next for Fannie and Freddie under Trump administration?

Is the stage finally set for transcontinental rail mergers?